The Application of Perfluoroheteroaromatic Reagents in the Preparation of Modified Peptide Systems by Gimenez, D et al.
Journal Name  
ARTICLE 
This journal is © The Royal Society of Chemistry 20xx J. Name., 2013, 00, 1-3 | 1  
Please do not adjust margins 
Please do not adjust margins 
a. Department of Chemistry, Durham University, South Road, Durham, DH1 3LE, U.K. 
b. School of Pharmacy and Biomolecular Sciences, Byrom Street Campus, Liverpool 
John Moores University, Liverpool, L3 3AF, U.K. 
† Corresponding author.  
Electronic Supplementary Information (ESI) available: [details of any 
supplementary information available should be included here]. See 
DOI: 10.1039/x0xx00000x 
Received 00th January 20xx, 
Accepted 00th January 20xx 
DOI: 10.1039/x0xx00000x 
www.rsc.org/ 
Application of Pentafluoropyridine and Related Polyfluorinated 
Reagents in the Preparation of Modified Peptide Systems  
Diana Gimenez,a Caitlin  A. Mooney,a Anica Dose,a Graham Sandford,a Christopher R. Coxonb† and 
Steven L. Cobba† 
Pentafluoropyridine has proved to be a highly reactive electrophile, undergoing SNAr arylation reactions in the presence of 
a range of nucleophilic peptide side chains (i.e. cysteine, tyrosine, serine and lysine) under extremely mild conditions. By 
comparison, the less electrophilic hexafluorobenzene was shown to only react with cysteine residues. Moreover, we have 
shown how one-step peptide-modification using perfluoroheteroaromatics can deliver enhanced proteolytic stability in 
pharmaceutically-relevant peptides such as oxytocin.    
Introduction 
 Perfluoroheteroaromatic derivatives such as 
pentafluoropyridine (1), tetrafluoro-pyrimidine (2) and 
tetrafluoro-pyridazine (3) are highly useful building blocks for 
organic synthesis because, in principle, all fluorine atoms may 
be displaced by nucleophiles via regioselective, sequential 
nucleophilic aromatic substitution reactions (SNAr). Indeed, we 
have extensively used 1-3 as starting materials for the 
synthesis of a variety of highly-substituted heterocyclic 
derivatives,1-3 tuned glycosyl donors4 and polyfunctional ring-
fused scaffolds.5 In particular, 1 and 2 have been used as 
central multifunctional building blocks for the synthesis of a 
range of macrocyclic systems6 upon reaction with suitable 
bifunctional oxygen and nitrogen-centred nucleophiles (Figure 
1).  
Given the synthetic versatility and useful reactivity of 
perfluoroheteroaromatic systems with nucleophilic species, it 
was envisaged that they would be extremely attractive 
reagents to exploit within the field of peptide chemistry. We 
postulated that they could be reacted with nucleophilic amino 
acid residues (i.e. serine, cysteine and lysine) to introduce a 
reactive handle for peptide modification and ‘tagging’; and 
also as a route to access cyclic or “stapled” peptide scaffolds. 
To this end, as part of an ongoing wider research programme 
in perfluoroheterocyclic chemistry, we previously reported 
that orthogonally protected serine derivatives can be 
successfully arylated with pentafluoropyridine (1) to afford 
novel amino acids such as 4, which could then be utilised as a 
building block in peptide synthesis7 (Figure 2). 
 
 
We were also able to demonstrated that (1) can be utilised 
as a threonine dehydrating agent to give access to novel 
dehydrobutyrines, such as 6, under mild reaction conditions 
(e.g. inorganic base, room temperature).8 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 1. Multifunctional heterocyclic systems and macrocycles synthesised from 
pentafluoropyridine (1), tetrafluoropyrimidine (2) and tetrafluorpyrazine (3) 
To further develop our research programme in this area, 
we sought to investigate the direct reaction of 
pentafluoropyridine (1) and related reagents with various 
peptide substrates. Herein, we present our findings concerning 
the reaction of a focussed range of perfluoroheteroaromatic 
derivatives with model cysteine, serine and lysine containing 
peptides. 
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Figure 2. Example of pentafluoropyridine ‘tagged’ serine aminoacid 4 reported by 
Hudson et al.7 This modified building block was further demonstrated to be compatible 
with peptide elongation into a model trimeric sequence (5). N-fluoropyrinidyl 
dehydrobutyrine 6, having a specific Z-alkene geometry, as synthetized by Webster et 
al.8  
Within the presented work, we demonstrate the ability of 
reagents such as 1 to tag nucleophilic peptide side chains 
beyond the routinely accessed cysteine. We have also 
demonstrated the use our peptide-tagging methodology to 
prepare novel analogues of the well-known cyclic peptides, 
oxytocin and vasopressin, to probe the effects of such 
modifications on physicochemical properties, such as 
proteolytic stability. 
Results and Discussion 
A series of simple linear model peptides based on the 
sequences reported by Pentelute et. al., 9-10 were synthesised 
by Fmoc solid phase peptide synthesis. The sequences were 
selected to enable a comparison of the differences observed in 
reactivity between hexafluorobenzene (7) and 
pentafluoropyridine (1) based reagents. Model sequences 
used for these control peptides were as follows; AcNH-
[YXGGGXAL]-CONH2, were X is a cysteine residue (X = Cys, 
pep1), a serine residue (X = Ser, pep2) or a lysine residue (X = 
Lys, pep3). Details regarding the synthesis of each peptide are 
provided the Supporting Information (Figures SI01-03). 
 
Exploring the scope of perfluoroaromatics for the SNAr-tagging of 
cysteine side chains 
Initially, we investigated the reactivity of 1 towards sulfur-
based nucleophiles (i.e. cysteine containing pep1). When 
peptide pep1 was reacted in DMF with 25 molar equivalents of 
hexafluorobenzene (7), pentafluoropyridine (1), or related 
perfluoropyridine-based electrophiles (8-10) in the presence of 
DIPEA (this is tagging method A, as described in ESI page 9), 
significant differences in reaction outcomes were observed as 
summarised in Table 1.  
As expected, hexafluorobenzene (7) arylated thiol based 
pep1 to generate the corresponding “stapled” peptide 11, in 
full agreement with previous reports9,10 (Table 1, Entry 1). In 
the case of pentafluoropyridine (1), the introduction of the 
nitrogen atom into the aromatic ring strongly increases the 
electron-deficient character of the electrophilic system as 
compared with hexafluorobenzene (7). Given this enhanced 
electrophilic character, (1) reacted with pep1 to give the linear 
tri-tagged peptide 12 as the main product. 12 is generated via 
1 reacting with both the cysteine residues and the tyrosine 
hydroxyl group (Table 1, Entry 2). The formation of “stapled” 
peptide products via reaction with hexafluorobenzene (7) has 
been proposed to proceed through two sequential SNAr 
steps.9-13 After the initial substitution, a linear ‘mono-tagged’ 
intermediate is formed, where electronic charge density can 
be displaced from the positions ortho- and especially in para- 
to the sulfur atom, further activating the intermediate towards 
a second SNAr reaction step. In contrast, pentafluoropyridine-
tagged linear intermediates, containing the aromatic nitrogen 
atom para to the new substituent can only cyclise though the 
more sterically hindered ortho-position. Given this competition 
is set up between cyclisation (intramolecular) and further 
tagging (intermolecular). Under the reaction conditions used 
(method A) 1 is used in a significant excess and as such the 
linear peptide 12 emerges as the main product. Interestingly, 
reports of sulfur nucleophiles reacting with 
pentafluoropyridine (1) are not well document in the 
literature.14-16  
Substituents will affect the reactivity of 1 towards 
nucleophilic attack and to probe this, aniline variants of 1 
where investigated as electrophiles in the reaction with pep1.  
Electrophiles 8-10 (Table 1) displayed significantly different 
reactivity profiles to 1, as exemplified by 4-
aminotetrafluoropyridine (8), which was found to be 
completely unreactive (Table 1, Entry 3, ESI Figure SI06); and 
the 3,5-dichlorinated electrophile 10, which afforded a 
complex mixture of products (Table 1, Entry 5). From this 
 
Entry Method ArF Comments/ Products formed 
1 A 
 
 
2 A 
 
 
3 A 
 
NO REACTION 
4 A 
 
NO REACTION 
5 A 
 
Complex mixture including: 
 
Table 1. Main products observed for the SNAr reactions of hexafluorobenzene (7) and 
related pyridine-based perfluoroaromatic reagents (1, 8-10) in the presence of 1/25 
molar equivalents of thiol based nucleophilic peptide Pep1, employing organic DIPEA 
as a base in DMF. Reaction conditions as described for method A. 
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mixture, only compound 13, a trifluoroacetate-adducted 
species with m/z = 1018 Da, could be isolated and successfully 
assigned as the mono-tagged peptide (ESI Figure SI08). Site 
directed tandem MS/MS spectrometry corroborated that 13 
exists as a mixture of regioisomers where the presence of the 
fluoroaromatic moiety can be located at either of the two 
cysteines available (ESI Figures SI28-30). 
 
Effect of peptide/electrophile ratio, concentration and 
temperature 
Following on from the formation of the linear tri-tagged 
peptide 12, we were keen to investigate if reaction conditions 
could be optimised that would allow selective tagging with 1 at 
either the cysteines (di-tagged product) or tyrosine (mono-
tagged product). To do this we directed our attention to 
probing the effects produced by changing the peptide: 
perfluoroaromatic ratio, concentration and reaction 
temperature. We hypothesised that a cyclic product would 
more likely be produced if the reaction was carried out in the 
presence of near-equimolar peptide and perfluoroaromatic 
and/or high-dilution conditions, by reducing partially the 
availability of the free electrophile in the reaction. Therefore, 
we varied the conditions initially used (method A) and ran 
reactions employing: only 5 equivalents of pentafluoropyridine 
(1) (method B), 5x dilution (method C) or elevated reaction 
temperature (50°C, method D). Interestingly, none of the new 
reaction conditions investigated appeared to have a significant 
impact on the major product outcome. In all examples, where 
1 was used as the electrophile the main product formed was 
the corresponding linear tri-tagged compound (12). 
 
Non-sulfur based nucleophiles: perfluoroaryl-tagging of serine and 
lysine based peptides 
Having explored the application of cysteine as a 
nucleophile we then proceeded to analyse the reaction of 
hexafluorobenzene (7) and pentafluoropyridine (1) with 
analogous model peptides with either oxygen (X = Ser, pep2) 
or a nitrogen (X = Lys, pep3) centred nucleophile-containing 
amino acid pairs. The results obtained are outlined in Table 2. 
Hexafluorobenzene (7), which readily reacted with cysteine to 
generate a cyclic peptide 11 was found to be completely 
unreactive towards the nucleophilic attack by any of the non-
sulphur based nucleophiles present (Table 2, Entries 6-7, ESI 
Figures SI13-14). Despite this it should be noted that recently 
Pentelute et al. demonstrated an elegant route through which 
arylation at lysine could be achieved if a perfluorosulfone 
derivative of hexafluorobenzene is utilised.17 In comparison to 
7, the more reactive pentafluoropyridine (1) was able to react 
with the lysine residues and the aromatic alcohol of the 
tyrosine residue under the same conditions (compounds 14 
and 15, Table 2, Entries 8 and 9, ESI Figures SI15-16). It is 
noteworthy that no product derived from the reaction of 
pentafluoropyridine (1) with the serine aliphatic alcohol was 
observed. The tandem MS/MS fragmentation pattern of the 
isolated product 14 clearly showed that the fluoropyridine 
moiety was attached specifically at the tyrosine residue (ESI 
Figures SI31 and SI32). In addition, the presence of only one 
single pair of 19F-NMR signals, at δ = -91.32 and -155.98 ppm, 
allowed the designation of the relative position of the ether 
group at the ring as para- to the aromatic nitrogen (ESI Figure 
SI33). The selective formation of 14 indicated that under the 
reaction conditions employed (method A) tagging with 1 had 
specificity for aromatic hydroxyl nucleophiles (Tyr) over 
aliphatic hydroxyls (Ser). The formation of 14 was a somewhat 
unexpected result given that we had previously reported that 
1 readily reacts at room temperature with individual serine 
and threonine amino acid derivatives7,8 (Figure 2).  
 By comparing the 19F NMR signals observed for compound 
14, with the corresponding spectra of compounds 12 and 15, it 
was possible to assign the chemical shifts arising from the 
fluorine atoms at the rings that have been substituted by 
cysteine and lysine residues. In both products, the presence of 
two pairs of 19F-NMR signals corresponding to the fluorine 
atoms located in ortho- and meta- positions relative to the 
aromatic nitrogen, provided evidence that also these reactions 
proceeded via the specific SNAr substitution of the fluorine 
atom located para- to the nitrogen (Table 3 and see ESI 
Figures SI27, 33 and 36 respectively).  
 
 
 
19F-NMR observed chemical shifts 
δ(ppm) 
X = Cys δF1 = -93.42 , δF2 = -137.49 
X = Lys δF1 = -98.17 , δF2 = -165.54 
X = Tyr δF1 = -91.32, δF2 = -155.98 
X = Ser δF1 = -97.10, δF2 = -165.92 
Table 3. Assignment of the 19F-NMR chemical shifts arising from the 
pentafluoropyridine moiety substituted para to the aromatic nitrogen through 
cysteine, lysine, tyrosine or serine residues. 
Evaluating the selection of base in the SNAr reaction: Organic 
DIPEA vs inorganic Cs2CO3 
Entry ArF 
Peptide 
(X=) 
Products formed 
6 
 
Ser NO REACTION 
7 Lys NO REACTION 
8 
 
Ser 
 
9 Lys 
 
Table 2. Main products observed for the SNAr reactions of pentafluoropyridine (1) 
and hexafluorobenze (7) with model hydroxyl and amine based peptides Pep2 and 
Pep3. Reaction conditions as described for method A. 
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In order to determine the effect of the base utilised on the 
reactivity we replaced the organic base DIPEA with an 
inorganic base (Cs2CO3). The isolated products from the 
reactions carried out using Cs2CO3 in the presence of 25 molar 
equivalents of hexafluorobenzene (7) or pentafluoropyridine 
(1) are shown in Table 4 and Table 5 respectively.  Swapping 
from DIPEA to Cs2CO3 generated several interesting results. For 
example, the di-serine containing peptide (pep2) was found to 
react with hexafluorobenzene (7) generating a mixture of 
products (Entry 11, Table 4, ESI Figure SI18), despite no 
observable reaction being detected when the reaction was run 
in the presence of DIPEA (Entry 6, Table 2). The main reaction 
product corresponded to the mono-tagged peptide 16 (for 
isolated product data see ESI). As expected from previous 
observations, it was confirmed that reaction had proceed 
specifically through the tyrosine and not a serine residue, as 
evidenced by the fact that only 3 signals were observed by 19F- 
NMR (ESI Figure SI39). 
 
 
Entry 
Peptide 
(X =) 
Main product observed 
Product 
ratio* 
 
10 
 
Cys 
 
 
 
 
11 
 
Ser 
 
 
5 
 
 
3 
 
 
1 
 
12 
 
Lys NO REACTION  
Table 4. Main products observed for the SNAr reactions of hexafluorobenzene (7) with 
model cysteine, serine and lysine based peptides Pep1-Pep3 when employing inorganic 
Cs2CO3 (25 mM) as a base. *Product ratio as evaluated from the crude reaction mixture 
by LC/MS chromatography at λ = 220 nm 
In addition, it was interesting that the dehydrated 
asymmetric cyclic peptide (17) and the doubly-dehydrated 
mono-substituted product (18) were also obtained. The 
presence of both suggests that cyclization prevents serine 
dehydration. The isolation and characterisation of both 
secondary products (17 see ESI Figures SI40-42 and 18 see ESI 
Figure SI043-045) confirmed their identity and structures 
(Table 4). It should also be noted that to the best of our 
knowledge, 17, represents the only reported example of an 
asymmetric perfluoro-aromatic stapled peptide.  
As a general trend, it was observed that in the presence of 
Cs2CO3, a more complex mixture of products was obtained 
when compared with the same reactions carried out using 
DIPEA. For example, in the reaction of Cs2CO3/ 
pentafluoropyridine (1) with the di-cysteine peptide (pep1) 
several products were isolated (Entry 13, Table 5, ESI Figure 
SI20) but with DIPEA (Entry 2, Table 1) the linear tri-tagged 
product 12 was the major product formed and isolated in the 
reaction. Furthermore, in the presence of Cs2CO3 additional 
products included the di-tagged peptides 19a and 19b (ESI 
Figures SI46-48) and the mono-tagged peptides 20a, 20b and 
20c (ESI Figures SI49-51), both of which were isolated as 
inseparable mixtures.   
A complex mixture of products was also observed when 
the reaction of the di-serine peptide pep2 with electrophile 1 
was analysed (Entry 14, Table 5, ESI Figure SI21). In the 
presence of Cs2CO3, 1 was able to undergo SNAr reactions at 
both tyrosine and serine residues as indicated by 19F NMR 
analysis. For example, unlike previously observations when 
using DIPEA, where tagging occurred exclusively at the 
tyrosine residue, analysis by 19F NMR of 22a and 22b revealed 
two distinct sets of fluorine signals corresponding to the 
tetrafluoropyridine motif attached to the tyrosine (δF1 = -
91.32, δF2 = -155.98 ppm) and the serine residue (δF1 = -97.10 
and δF2 = -165.96 ppm). In both cases the hydroxyl 
nucleophile had replaced the fluorine atom located in the 
para- position to the ring nitrogen (ESI Figure SI57). The linear 
tri-tagged peptide 23 (ESI Figures SI58-60) was obtained in the 
reaction but only as a minor product.  
In agreement with earlier observations where DIPEA was 
utilised as a base, the reaction with the lysine-containing 
peptide, pep3 led to the formation of the linear tri-tagged 
peptide 15 as the major product (Table 5, Entry 15, ESI Figure 
SI22). 
 
 
Exploring the potential application of perfluoro-‘tagging’ to 
enhance peptide bio-stability 
We hypothesised that perfluoroaromatic tagging could be 
utilised to add steric bulk to amino acid residues and thus 
‘protect’ peptides from undergoing enzymatic degradation. As 
such, we proceeded to synthesise novel derivatives of two 
bioactive peptide hormones, which typically have short half-
lives in vivo.18-19 
Oxytocin (25) and vasopressin (26) share a common cyclic 
core structural motif, which has been shown to be particularly 
sensitive to chymotrypsin-mediated enzymatic amide bond-
hydrolysis, at the aromatic Tyr and the C-terminal glycine 
residue, leading to the formation of inactive linear 
fragments.20-21 
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Due to their pharmacological relevance, different 
strategies have been employed in an effort to obtain 
analogues of 25 and 26 with enhanced stability, such as the 
incorporation of unnatural amino acids at the C-terminus22, 
amide bond head to tail cyclization and replacement of the 
disulfide bridge.23 For example, carbetocin is an oxytocin 
analogue wherein the C-terminal glycine has been de-
aminated, tyrosine residue alkylated (OH to OMe) and the 
disulfide bond chemically modified.24 While, carbetocin does 
display enhanced bio-stability, its synthesis compared to 
oxytocin, is considerably more complex. We envisaged that the 
“tagging” of oxytocin using perfluoroaromatics in a simple one-
step process could offer a relatively mild and cost effective 
route by which alter its enzymatic stability.  
 
 
Figure 3. Natural cyclic peptide hormones oxytocin (25) and vasopressin (26) and their 
corresponding ‘perfluoroaryl-tagged’ analogues 27 and 28. 
The reaction of oxytocin (25) and vasopressin (26) in the 
presence of 5 equivalents of pentafluoropyridine (1), and 
DIPEA in DMF afforded a mixture of mono- and di-tagged 
derivatives (data not presented). In order to afford di-tagged 
peptides in a more efficient manner the reaction was repeated 
using the more reactive tetrafluoropyridazine (24). Reaction of 
peptides 25 and 26 with electrophile 24 proceeded to give the 
di-tagged peptides with very little trace of mono-tagging 
observed in the crude reaction mixture. Di-tagged peptides 27 
and 28 were isolated, purified and analysed by tandem MS/MS 
and 19F NMR to confirm that tagging had occurred at the 
tyrosine residue and N-terminus (see ESI Figures SI61-63 for 
compound 27, and Figures SI64-66 for compound 28). 
The bio-stability of 27 and 28 were analysed and compared 
to the non-tagged parent peptides (25 and 26 respectively) via 
incubation with chymotrypsin at 20°C for 24hrs 
(peptide/enzyme ratio 25:1; Tris buffer 50 mM, pH 7.4). The 
ratio of the remaining intact peptide/digested peptide was 
followed by analytical RP-HPLC (λ = 220 nm), with sample 
aliquots taken and analysed at different times over a 24hr 
period. Standard control samples containing peptides 25 - 28 
but no enzyme were also performed (see ESI Figures SI71A-D). 
After 24hrs the digested samples were analysed by MALDI-
ToF spectrometry in order to assess the identity of any peptide 
fragments present. Significant differences in the digestion 
profiles were found when we compared the non-tagged (25 
and 26) vs. the tagged analogues (27 and 28) (Figures 4 and 5). 
Entry 
Peptide 
(X =) 
Main product(s) observed 
Product 
ratio** 
13 Cys 
 
3.9 
 
1* 
 
 
1.6* 
14 Ser 
 
3.7* 
 
1* 
 
1.2 
15 Lys 
 
 
Table 5. Main products observed for the SNAr reactions of pentafluoropyridine (1) 
with model cysteine, serine and lysine based peptides Pep1-Pep3 when employing 
inorganic Cs2CO3 as a base. *Mixture of regio-isomers as determined by 19F-NMR and 
MS/MS spectrometry. **Product ratio as evaluated from the crude reaction mixture 
by LC/MS trace at λ=220nm. 
ARTICLE Journal Name 
6 | J. Name., 2012, 00, 1-3 This journal is © The Royal Society of Chemistry 20xx 
Please do not adjust margins 
Please do not adjust margins 
 As illustrated in Figures 4A-C the natural non-tagged 
oxytocin 25 was found to be relatively quickly digested at the 
amide bond adjacent to the Tyr, resulting in the opening of the 
macrocyclic core motif. Further hydrolysis at the C-terminal 
glycine residue afforded a linear fragment (as seen in Figure 
4C). By comparison, we only observed a single digestion 
product when the tagged-oxytocin 27 was subjected to the 
same digestion process. In this system no hydrolysis of the Tyr-
Ile amide bond was observed leaving the core ring structure 
intact (see Figure 4D). Cleavage of the C-terminal glycine 
residue was still observed but this is to be expected as it was 
not modified or protected.   Similar results were obtained in 
when we carried out our analysis on the cyclic peptide 
vasopressin 26 and it’s tagged analogue 28 (ESI Figures SI69-
70). The tagged peptide 28 was found to partially retain its 
core cyclic structure but again complete loss of the C-terminal 
glycine was observed. Some enzymatic degradation of the core 
cyclic scaffold of 28 was observed due to hydrolysis of the Phe-
Gln amide bond (see structures in Figure 5). Overall, the 
results obtained demonstrate that modification of the tyrosine 
residue offer a method to protect enzymatic cleavage at that 
specific site (e.g. as in case of 27), but the enhanced steric bulk 
does not impart full protection at adjacent residues (i.e. Phe-
Gln amide bond in 28 is still partially cleaved).  
 
   
Figure 4. Evaluation of oxytocin (25, A) and perfluoroaryl-tagged oxytocin (27, B) digestion process in the presence of chymotrypsin, as analysed by RP-HPLC (λ = 220 nm). C) 
Structures corresponding to the final digested linear product observed in parent oxytocin, showing the hydrolysis of the Tyr-Ile amide bond. In comparison, perfluoroaryl-tagged 
Tyr residue in compound 27 was probed to be resistant to enzymatic digestion, preserving the initial cyclic structure of the product (D). Digestion sites are circled for clarity. 
 
A) 
Enzyme 
Oxytocin 25 
Tagged Oxytocin 27 
Digested 
Products 
Digested 
Products 
D) C) 
B)
) 
Enzyme 
 
Figure 5. Final digested products observed in parent vasopressin (26, A) and 
perfluoroaryl-tagged vasopressin (28, B), as assessed by MALDI-ToF analysis after 
digestion (24 hrs). When compared to the natural sequence, the perfluoroaryl-tagged 
derivative could not be hydrolysed by the enzyme at the chemically modified tyrosine 
residue.  Digestion sites are circled for clarity. 
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Conclusions 
We have shown that perfluoroheteroaromatic compounds can 
be successfully applied to access a range of modified peptides. 
Pentafluoropyridine (1) has proven to be a highly reactive 
electrophile, allowing SNAr mediated arylations to proceed in 
the presence of a range of nucleophilic side chains including 
cysteine, tyrosine, and lysine under extremely mild reaction 
conditions. By comparison, the less electrophilic 
hexafluorobenzene (7) was found to react only with sulfur-
based nucleophilic residues (i.e. cysteine). Electrophile 
concentration only had a minor impact on the reaction 
outcomes, yet the nature of the base used (organic or 
inorganic) did produce noticeable differences in product 
formation. In general when employing the inorganic base, 
Cs2CO3, we observed a significant increase in peptide “tagged” 
when compared with the use of DIPEA. By selecting the base 
we were able to obtain novel products such as the 
asymmetrically hydroxyl stapled peptide 17. The identification 
of reaction conditions and reagents that allow modification at 
non-cysteine side chains (i.e. tyrosine, serine and lysine), will 
add further scope to the rapidly expanding field of peptide 
SNAr arylation peptide chemistry.7-13,17,25-26 We were also able 
to demonstrated the application of ‘perfluoroaryl mono-
tagging’ as a means to modulate the bio-stability of two well-
known cyclic hormones, oxytocin (25) and vasopressin (26). 
While both parent peptides (oxytocin and vasopressin) were 
shown to be rapidly degraded by chymotrypsin, we 
demonstrated that a significantly increased enzymatic stability 
occurred upon perfluoroaryl-tagging. From this work, we 
propose that this type of site-specific perfluoroaryl-tagging 
could offer a simple and cost effective route by which to target 
and block digestion sites and thus improve the in vivo 
properties of known peptide drugs. 
Experimental 
Materials and general methods 
All chemicals and solvents were analytical grade and used 
without further purification. Liquid chromatography-mass 
spectrometry (LC/MS; ESI+) analyses were performed on a 
Waters Acquity UPLC BEH C18 column (1.7 μm, 2.1 mm x 50 
mm) using a Waters Acquity UPLC system equipped with a 
photodiode array detector, providing absorbance data from 
210 nm to 400 nm. A gradient with eluent I (0.1% HCOOH in 
water) and eluent II (0.1% HCOOH in acetonitrile) rising linearly 
from 5 to 95% of II during t = 0.2–4.0 min was applied at a flow 
rate of 0.6 mL/min after 0.2 min of 95% solvent I equilibration. 
High-resolution QToF-LC/MS  and QToF-MS/MS analyses were 
performed on a Acquity UPLC BEH C18 column also (1.7 μm, 
2.1 mm x 50 mm) using a Waters Acquity UPLC system coupled 
in this case to a Micromass QToF Premier mass spectrometer, 
also equipped with a photodiode array detector providing 
absorbance data from 210 nm to 400 nm. A gradient with 
eluent I (0.1% HCOOH in water) and eluent II (0.1% HCOOH in 
acetonitrile) rising linearly from 0 to 99% of II during t = 0.0–
5.0 min was applied at a flow rate of 0.6 mL/min. 19F-NMR 
spectra studies were recorded at 376 MHz in a Bruker Advance 
spectrometer at 298 K, using 8 scans with a relaxation delay of 
1s. All data has been processed using Mestrenova® software.  
Solid phase synthesis of model peptides pep1-pep3 
Each of the described peptide sequences was prepared using 
automated Fmoc-SPPS methods on a Liberty 1 peptide 
synthesiser (CEM) with microwave-assisted couplings (single 
coupling per amino acid; 10 min, 75 °C or 50 °C for Fmoc-
Cys(Trt)-OH coupling). Solid phase synthesis was conducted 
using Rink amide resin (0.7 mol/g loading) on a 0.1 mmol scale, 
employing HBTU and DIPEA as the activator and base, 
respectively. Standard acid-sensitive amino acid side chain 
protecting groups e.g. Boc, tBu, trityl were employed. 
Following the on-resin growing of the appropriate sequence, 
N-terminal acetylation was achieved by using a solution of 
Ac2O in DMF (20% v/v, 5 mL) while shaking at room 
temperature for 15 min. Once completed, the beads were 
washed with DMF three times and the acetylation step 
repeated. The resin was then carefully washed with DMF, 
MeOH and DCM (3 x 10 mL). Finally, peptides were cleaved 
from the resin as the corresponding C-terminal amides by 
treatment with a mixture of TFA/TIPS/H2O 95:5:5% v/v (2 mL) 
at room temperature for 4 h. After removal of volatiles under 
vacuum, the product was triturated and carefully washed with 
Et2O (3 x 10 mL). The final precipitated solid residue was then 
re-dissolved in H2O/TFA 99:1 (15 mL) and lyophilised affording 
the corresponding peptides as a white/yellow powder. The 
crude peptides were used without further purification. 
 
General procedure for solution phase peptide tagging and stapling 
with perfluoroaromatics 
Solid crude peptides pep1-3 (2 mg, approx. 2.5 µmol) were 
dissolved in DMF (0.5 mL) in a 1.5 ml plastic Eppendorf tube, to 
which a Cs2CO3 or DIPEA stock solution (50 mM in appropriate 
solvent, 0.5 mL) was then added. 25 equivalents of the 
corresponding perfluoroaromatic were slowly added and the 
tube was shaken vigorously at room temperature for 4.5 h 
(method A, unless otherwise stated). After removal of volatiles 
under vacuum, all products were dissolved in an 8:1:1 mixture 
of DMF/H2O/MeCN (1 mL) and characterised by LC/MS (ESI+). 
When formation of novel compounds was observed, 10-fold 
scaled reactions were employed in all cases for product 
isolation in order to afford a complete characterisation.  
 
Product isolation and characterization 
Products from the large-scale reactions were purified and 
isolated by semi-preparative reverse phase HPLC performed 
on a Discovery Bio wide pore C18-5 column (Supelco; 5 μm, 25 
cm × 10 mm), using a Pelkin-Elmer 200 LC pump coupled to a 
Waters 486 tunable absorbance detector settled up at λ = 220 
nm. A gradient with eluent A (95:5:0.1% H2O:MeCN:TFA) and 
eluent B (5:95:0.1% H2O:MeCN:TFA) was applied, where eluent 
B increased linearly from 0 to 100% over 40 min. Purified 
pooled fractions were then freeze-dried and analysed by 
LC/MS. The desired pure peptide products were then further 
characterised by 19F NMR (2 mg/mL in H2O/CD3CN 1:1, unless 
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otherwise stated), high resolution QToF-LC/MS and ion 
directed tandem mass spectrometry (MS/MS). 
 
General procedure for oxytocin and vasopressin-tagging 
Commercially available C-teminal amide oxytocin was obtained 
from Cayman Chemical Co., and vasopressin was purchased 
form Apollo Scientific Ltd. Both peptides were used as starting 
materials without any further purification. In both cases 10 mg 
of the peptide was dissolved in 5 mL of DMF to which another 
5 mL of a freshly made stock solution of DIPEA 50 mM in DMF 
was then added. Solutions where placed in argon flushed 
chemically-resistant syringes, and 25 equivalents of either 
pentafluoropyridine or tetrafluoropyridazine were slowly 
added. The systems were reacted with vigorously shaking at 
room temperature for 4.5 h. After removal of DMF and 
volatiles under vacuum, the remaining oily residue was 
dissolved in H2O/MeCN (10 mL) and freeze-dried. Crude 
materials were characterised by LC/MS (ESI+) to confirm the 
presence of the desired products and further purified by semi-
preparative HPLC (as described previously). Isolated 
compounds were further characterised by 19F-NMR (2 mg/mL 
in CD3CN), high resolution QToF-LC/MS and ion directed 
tandem mass spectrometry (MS/MS).  
 
General procedure for enzymatic digestion using chymotrypsin 
For the bio-stability assays α-chymotrypsin, from bovine 
pancreas, was purchased from Sigma-Aldrich. Peptides were 
dissolved in a stock solution of Tris buffer (25 mM, pH 7.6) up 
to a concentration of 1 mg/mL concentration.  Simultaneously 
a freshly made stock solution of enzyme in the same chilled 
buffer was prepared. The samples were immediately prepared 
by mixing in a polypropylene microcentrifuge tube an aliquot 
of 100 µL of peptide solution with the corresponding amount 
of enzyme stock solution to afford a final peptide to enzyme 
ratio of 25:1. The sample mixtures were then incubated in a 
thermally controlled water bath at 20ºC for a minimum of 24 
h. During the incubation time, 15 µL aliquots of sample 
mixture were withdrawn at different times, quenched at once 
with 15 µL of 30% MeCN/TFA solution and analyzed by 
analytical reverse phase HPLC, employing a X-Bridge C18 
column (5.3 µm, 4.6 x 100 mm, 40°C) in a Pelkin-Elmer 200 
series LC system equipped with auto-sampler, UV/Vis-detector 
and a Peltier column oven. In all samples a linear gradient 
rising from eluent A (95:5:0.05% H2O:MeCN:TFA) to 100% of 
eluent B (5:95:0.03% H2O:MeCN:TFA) over t = 30 min plus 5 
min of isocratic B elution was applied at a constant flow rate of 
1 mL/min. Detection was performed at λ = 220 nm. The signals 
corresponding to both peptide and enzyme in the raw 
chromatograms were baseline corrected and then fitted into 
separate Gaussian equations using Origin8 software. The area 
enclosed by each function was taken as the peak neat 
integrated area. The ratio of non-digested peptide is then 
estimated as: 
𝑃𝑒𝑝𝑡𝑖𝑑𝑒 𝑅𝑎𝑡𝑖𝑜 =
[𝑃𝑒𝑝𝑡𝑖𝑑𝑒 𝐴𝑟𝑒𝑎 𝐸𝑛𝑧𝑦𝑚𝑒 𝐴𝑟𝑒𝑎⁄ ]𝑡
[𝑃𝑒𝑝𝑡𝑖𝑑𝑒 𝐴𝑟𝑒𝑎 𝐸𝑛𝑧𝑦𝑚𝑒 𝐴𝑟𝑒𝑎⁄ ]𝑡=0
 
 
For each peptide a minimum of two independent assays were 
performed, and the final Peptide Ratio vs Incubation time 
analysed in terms of an exponential decay behaviour where:  
 
𝑃𝑒𝑝𝑡𝑖𝑑𝑒 𝑅𝑎𝑡𝑖𝑜 = 𝑦0 + 𝐴𝑒
−𝑘𝑡  
 
Control samples were run by subjecting each peptide to the 
same procedure and conditions using the corresponding 
volume of Tris buffer in the absence of enzyme.  
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